WLK WESTLAKE CORP
Industrial Organic Chemicals · NYSE · SEC CIK 1262823 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-0.4%
TTM net income YoY53.3%
TTM EPS YoY53.2%
Revenue 3-yr CAGR-4.2%
Net income 3-yr CAGR—
Margins
Gross margin10.8%
Operating margin-3.8%
Net margin-3.9%
FCF margin0.1%
EBITDA margin6.3%
Returns
ROE-4.9%
ROA-2.3%
ROIC (approx.)-2.9%
Asset turnover0.59x
Leverage & solvency
Liabilities / assets52.5%
Debt / equity0.58x
Current ratio2.38x
Interest coverage-2.04x
Cash quality & payout
Operating cash flow / net income-1.89x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue7.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.98B | $3.27B | $2.65B | $2.53B | $2.84B | $2.95B | $2.85B | $2.84B |
| Cost of revenue | $2.60B | $2.62B | $2.54B | $2.45B | $2.60B | $2.69B | $2.61B | $2.52B |
| Gross profit | $382.00M | $652.00M | $112.00M | $87.00M | $236.00M | $258.00M | $232.00M | $328.00M |
| SG&A expense | $250.00M | $253.00M | $236.00M | $224.00M | $228.00M | $221.00M | $227.00M | $226.00M |
| Operating income | $43.00M | $364.00M | -$172.00M | -$671.00M | -$766.00M | -$109.00M | -$32.00M | $66.00M |
| Interest expense | $52.00M | $55.00M | $56.00M | $51.00M | $41.00M | $40.00M | $39.00M | $39.00M |
| Pretax income | $8.00M | $338.00M | -$190.00M | -$663.00M | -$775.00M | -$125.00M | -$34.00M | $96.00M |
| Income tax | -$10.00M | $67.00M | -$33.00M | -$130.00M | -$3.00M | $6.00M | $1.00M | $77.00M |
| Net income | $6.00M | $260.00M | -$169.00M | -$544.00M | -$782.00M | -$142.00M | -$40.00M | $7.00M |
| EBITDA | $333.00M | $650.00M | $112.00M | -$374.00M | -$463.00M | $186.00M | $251.00M | $347.00M |
| EPS (basic) | 0.05 | 2.02 | -1.31 | — | -6.06 | -1.11 | -0.31 | — |
| EPS (diluted) | 0.05 | 2.01 | -1.31 | — | -6.06 | -1.11 | -0.31 | — |
| Dividends declared per share | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.52 |
| Weighted avg. shares (diluted) | 127.96M | 128.50M | 127.99M | — | 128.25M | 128.24M | 128.31M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.76B | $1.64B | $2.27B | $2.72B | $1.94B | $2.10B | $2.31B | $2.94B |
| Short-term investments | $207.00M | $209.00M | $205.00M | $204.00M | $198.00M | $192.00M | $183.00M | $0 |
| Receivables | $1.49B | $1.69B | $1.36B | $1.23B | $1.43B | $1.59B | $1.46B | $1.31B |
| Inventory | $1.81B | $1.75B | $1.68B | $1.65B | $1.73B | $1.73B | $1.78B | $1.70B |
| Current assets | $5.64B | $5.69B | $5.95B | $6.22B | $5.75B | $5.95B | $6.02B | $6.21B |
| PP&E, net | $8.60B | $8.65B | $8.58B | $8.61B | $8.82B | $8.83B | $8.67B | $8.63B |
| Goodwill | $1.35B | $1.35B | $1.34B | $1.31B | $1.31B | $2.04B | $2.03B | $2.03B |
| Intangibles | $720.00M | $741.00M | $763.00M | $743.00M | $765.00M | $785.00M | $802.00M | $820.00M |
| Total assets | $19.27B | $19.44B | $19.71B | $19.96B | $19.81B | $20.81B | $20.71B | $20.75B |
| Current liabilities | $2.37B | $2.32B | $2.74B | $2.77B | $2.90B | $2.40B | $2.29B | $2.22B |
| Short-term debt | $0 | $0 | $496.00M | $497.00M | $750.00M | $3.00M | $4.00M | $6.00M |
| Long-term debt | $5.06B | $5.07B | $5.07B | $5.09B | $3.91B | $4.65B | $4.59B | $4.56B |
| Total debt | $5.06B | $5.07B | $5.57B | $5.58B | $4.66B | $4.66B | $4.59B | $4.56B |
| Total liabilities | $10.11B | $10.23B | $10.66B | $10.67B | $9.88B | $10.02B | $9.79B | $9.71B |
| Shareholders' equity | $8.66B | $8.71B | $8.55B | $8.79B | $9.43B | $10.28B | $10.41B | $10.53B |
| Net debt | $3.30B | $3.42B | $3.30B | $2.86B | $2.71B | $2.56B | $2.28B | $1.63B |
| Cash flow statement | ||||||||
| Operating cash flow | $395.00M | $318.00M | -$94.00M | $225.00M | $182.00M | $135.00M | -$77.00M | $434.00M |
| Capital expenditure | $175.00M | $207.00M | $209.00M | $241.00M | $239.00M | $267.00M | $248.00M | $285.00M |
| Free cash flow | $220.00M | $111.00M | -$303.00M | -$16.00M | -$57.00M | -$132.00M | -$325.00M | $149.00M |
| Investing cash flow | -$188.00M | -$320.00M | -$271.00M | -$255.00M | -$242.00M | -$292.00M | -$434.00M | -$265.00M |
| Financing cash flow | -$85.00M | -$622.00M | -$82.00M | $815.00M | -$88.00M | -$82.00M | -$115.00M | -$133.00M |
| Depreciation & amortization | $290.00M | $286.00M | $284.00M | $297.00M | $303.00M | $295.00M | $283.00M | $281.00M |
| Stock-based compensation | $12.00M | $13.00M | $7.00M | $11.00M | $11.00M | $12.00M | $7.00M | $10.00M |
| Dividends paid | $68.00M | $69.00M | $68.00M | $68.00M | $68.00M | $68.00M | $68.00M | $67.00M |
| Share buybacks | $0 | $30.00M | $0 | $33.00M | $0 | $0 | $30.00M | $60.00M |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.